
Network News

A new level of efficiency, precision and sustainability in UV/Vis spectroscopy PHABIOC GmbH announces the start of mass production of its innovative SpecPlate – a multiwell plate designed specifically for the needs of pharmaceutical and biotech research. The SpecPlate sets new standards in plate-based UV/Vis spectroscopy by improving efficiency and precision while significantly reducing material […]
read more
When the aorta threatens to rupture: providing support instead of replacing it
A team of cardiac surgeons at Heidelberg University Hospital has implanted a new type of support for the aorta, the main artery, for the first time in Germany. The mesh, made of plastic, prevents the dangerous widening and tearing of the aorta in certain hereditary connective tissue diseases such as Marfan syndrome. The procedure offers […]
read more
Theodor Fliedner Medal: Innovation rooms in the head clinic honored
Since its foundation in November 2020, the innovation rooms at Heidelberg University Hospital have made a decisive contribution to the further development and optimization of patient-centered care. The innovative ward concept in the Head Clinic has now been awarded the Theodor Fliedner Medal. More Information in German below. Theodor-Fliedner-Medaille: Innovationsräume in der Kopfklinik ausgezeichnet Seit […]
read more
New vaccines offer hope for brain tumor patients
Michael Platten is the winner of the “Breakthrough of the Year 2024” in the Life Sciences category of the Falling Walls Foundation. Michael Platten’s research has a major goal: He wants to advance the cure of one of the deadliest forms of brain tumors, known as gliomas. His work has shown that the immune system […]
read more
IT security campaign of the four university hospitals in Baden-Württemberg receives award
Cyberattacks and analog attacks are a serious and ever-increasing threat to hospitals. In 2022, the Dr. Nope campaign at the four university hospitals in Baden-Württemberg demonstrated in a humorous way how employees can protect information and IT tools through their own personal behavior. The information security initiative has now been awarded the Security Prize at […]
read more
VectorBuilder’s Chief Scientist Dr. Bruce Lahn Named to Forbes China’s Top 100 Most Influential Chinese
Chicago, IL – November 14, 2024 — VectorBuilder, a global leader in gene delivery solutions, proudly announces that its chief scientist, Dr. Bruce Lahn, has been recognized on the 2024 Forbes China 100 Most Influential Chinese list. This distinguished annual selection honors 100 prominent Chinese figures shaping business, culture, and philanthropy globally, with past recipients including NVIDIA’s Jenson […]
read more
Oral diseases cost the world $710 billion annually
Caries, periodontitis and tooth loss cost billions of dollars worldwide every year. This is the result of a recent study at Heidelberg University Hospital and the Medical Faculty Heidelberg of Heidelberg University. Treatment costs for oral, dental and jaw diseases rank third in the EU, behind cardiovascular diseases and diabetes. The results of the study […]
read more
Green hydrogen for a climate-neutral industry: InnovationLab organizes Clean Tech Innovation Day
Heidelberg, Germany, November 6, 2024 – The technology transfer platform InnovationLab is looking forward to the premiere of a new event format: hydrogen experts from Germany and abroad are expected to attend the Clean Tech Innovation Day on Monday, November 11 (9 a.m. to 6 p.m.). Together with its two co-partners, the Rhine-Neckar metropolitan region […]
read more
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
Partnership to Combine AbbVie’s Oncology Expertise with EvolveImmune’s Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer NORTH CHICAGO, Ill. and BRANFORD, Conn., Oct. 31, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) and EvolveImmune Therapeutics, an immuno-oncology company developing next-generation biotherapeutics to overcome the therapeutic challenges of cancer cell resistance to current immunotherapies, today announced a collaboration […]
read more